Diabetes is a breakdown in the body's ability to produce or use insulin, the hormone the pancreas releases to move glucose from the bloodstream into cells for energy. Specialized cells called beta cells, located in clusters within the pancreas known as the Islets of Langerhans, produce insulin in response to rising blood sugar after eating. In Type 2 diabetes, beta cells become exhausted from years of insulin resistance and gradually stop producing enough insulin. In Type 1 diabetes, the immune system mistakenly destroys beta cells entirely, an autoimmune process confirmed by research from the National Institute of Diabetes and Digestive and Kidney Diseases. Without sufficient insulin, glucose accumulates in the blood rather than entering cells, causing the elevated blood sugar levels and long-term organ damage associated with diabetes, as documented by the CDC's National Diabetes Statistics Report.
Most people think of diabetes as a sugar problem. Eat too much sugar, get diabetes — that's the popular version. It's not wrong exactly, but it skips the part that actually matters: what's happening inside your pancreas, and why it stops doing its job.
Understanding the real mechanism changes how you think about treatment. It's the difference between managing a symptom and understanding a cause. So let's walk through it properly — what insulin actually does, why beta cells matter, and what physically goes wrong in Type 1 versus Type 2 diabetes.
What Insulin Actually Does
Insulin is a hormone produced by beta cells in the pancreas that allows glucose to move from your bloodstream into your cells, where it's converted into usable energy. Without enough insulin, or when cells stop responding to it properly, glucose accumulates in the blood instead of being absorbed — this is the core mechanism behind every form of diabetes.
Insulin was first isolated in 1921 by Frederick Banting and Charles Best at the University of Toronto — a discovery that transformed diabetes from a near-certain death sentence into a manageable chronic condition. More than a century later, the hormone's basic function remains the foundation of everything we understand about the disease.
Think of insulin as a key. Your cells have locks on their surface — insulin receptors. Glucose can't get into the cell without that lock being turned. Insulin is the only key that fits. When insulin attaches to the receptor, it triggers the cell to open channels (called GLUT4 transporters) that let glucose flow in. Without insulin, or if the lock mechanism is damaged, glucose simply piles up outside the cell, in your bloodstream.
This is why diabetes isn't really about sugar intake on its own — plenty of people eat sugar their entire lives without developing diabetes. It's about whether the lock-and-key system is functioning.
The Glucose Journey — Step by Step
After eating, carbohydrates are broken down into glucose, which enters the bloodstream and raises blood sugar. The pancreas detects this rise and releases insulin from beta cells. Insulin allows glucose to enter cells for energy, lowering blood sugar back to normal. In diabetes, this final step fails — either because not enough insulin is produced, or because cells resist its signal.
You eat food containing carbohydrates
Your digestive system breaks food down into glucose, which enters your bloodstream and causes blood sugar to rise. This is a completely normal process that happens after every meal — the question is what happens next.
The pancreas senses the rise in blood sugar
Specialized cells in the pancreas called beta cells — housed in clusters called the Islets of Langerhans — detect the change in glucose concentration and are triggered to produce and release insulin into the bloodstream.
Insulin acts as the "key" to your cells
Insulin travels through the blood and binds to receptors on muscle, fat, and liver cells, unlocking them so glucose can enter and be converted to energy or stored for later use. Blood sugar then drops back toward normal levels — a process the National Institute of Diabetes and Digestive and Kidney Diseases describes as central to metabolic regulation.
In diabetes, this system breaks down
The pancreas cannot produce enough insulin (Type 2 — worn-out beta cells, or insulin resistance) or produces none at all (Type 1 — autoimmune beta cell destruction). Glucose stays trapped in the blood, where it gradually damages blood vessels, nerves, kidneys, and eyes — a process well documented by the CDC's diabetes complications data.
- Insulin is the only hormone that allows glucose to enter most of your body's cells
- Beta cells, located in the Islets of Langerhans, are the sole producers of insulin in the body
- The glucose-insulin cycle happens every time you eat — diabetes is a breakdown somewhere in that cycle
- Type 2 diabetes involves both insulin resistance and progressive beta cell exhaustion
- Type 1 diabetes involves near-total destruction of beta cells by the immune system
The Pancreas: Where It All Happens
The pancreas is a gland located behind the stomach that serves two functions: producing digestive enzymes (exocrine function) and regulating blood sugar through hormone production (endocrine function). The endocrine portion contains roughly one million Islets of Langerhans, each housing beta cells that produce insulin, alpha cells that produce glucagon, and other supporting hormone-producing cells.
The Islets of Langerhans were first described in 1869 by German pathologist Paul Langerhans, then a 22-year-old medical student, who noticed unusual cell clusters scattered through pancreatic tissue without understanding their function. It would take several more decades before their hormone-producing role was understood.
Each islet contains several different cell types working together: beta cells producing insulin, alpha cells producing glucagon (insulin's opposing hormone, which raises blood sugar when needed), and smaller populations of delta and other cells fine-tuning the system. This is a tightly coordinated feedback loop — and diabetes represents a breakdown specifically in the beta cell component of it.
Diabetes isn't a sugar problem.
It's a beta cell problem — and the sugar is just what shows up on the test.
Type 1 vs Type 2: Two Different Mechanisms
Type 1 diabetes is an autoimmune condition where the immune system destroys insulin-producing beta cells, usually beginning in childhood or young adulthood and requiring lifelong insulin therapy. Type 2 diabetes develops gradually in adulthood as cells become resistant to insulin's effects and beta cells become exhausted trying to compensate, eventually producing insufficient insulin.
Exhausted Beta Cells
Years of insulin resistance — where muscle, fat, and liver cells stop responding well to insulin's signal — force the pancreas to produce increasing amounts of insulin to compensate. Over time, this overworking exhausts the beta cells. They gradually lose the ability to keep up, and insulin production declines even as the body's need for it increases. According to the CDC's National Diabetes Statistics Report, Type 2 accounts for 90-95% of diagnosed diabetes cases in the United States.
Autoimmune Attack
The immune system mistakenly identifies beta cells as a threat and destroys them directly, typically over a period of months to years. By the time symptoms appear, the majority of beta cell mass is often already gone. Because this is an immune-driven process rather than a metabolic exhaustion process, Type 1 diabetes requires insulin replacement therapy for life. Research from the NIDDK confirms it accounts for roughly 5-10% of diagnosed cases.
| Factor | Type 1 Diabetes | Type 2 Diabetes |
|---|---|---|
| Underlying cause | Autoimmune destruction of beta cells | Insulin resistance + progressive beta cell exhaustion |
| Typical onset | Childhood / young adulthood | Adulthood (though rising in younger populations) |
| % of diagnosed cases | 5–10% | 90–95% |
| Insulin production | Little to none | Reduced, declining over time |
| Reversibility | Not currently reversible | Often improvable with early intervention3 |
| Primary treatment | Lifelong insulin therapy | Lifestyle changes, oral medication, sometimes insulin |
| Lifestyle factor influence | Minimal | Significant |
Can Beta Cells Recover?
This is where ongoing research gets genuinely interesting. In Type 2 diabetes, beta cell exhaustion is largely driven by chronic inflammation and oxidative stress in pancreatic tissue — not necessarily permanent cell death. Studies published in the Journal of Ethnopharmacology have explored whether reducing this inflammatory burden can support some recovery of insulin-producing function, particularly when intervention happens before extensive cell loss has occurred.4
Type 1 diabetes is a different story. Because the destruction is immune-mediated, any new or regenerated beta cells would face the same autoimmune attack that destroyed the originals — which is why current research in Type 1 focuses heavily on immune modulation alongside any regenerative approaches, according to ongoing work tracked by the American Diabetes Association's research division.
The mechanistic distinction between Type 1 and Type 2 diabetes is well-established in endocrinology: one is autoimmune cell destruction, the other is a combination of peripheral insulin resistance and progressive beta cell fatigue. This distinction has direct treatment implications — Type 1 management centers on insulin replacement because there is no functioning beta cell population to support, while Type 2 management has more room to address the underlying drivers of beta cell stress.
What's increasingly clear from pancreatic research is that beta cell function in Type 2 diabetes exists on a spectrum, not a binary. Reducing the inflammatory and oxidative load on remaining beta cells — through diet, exercise, and certain anti-inflammatory compounds under active study — may help preserve or partially restore function, particularly earlier in the disease course. This reframes Type 2 diabetes management around a central question: how much functioning beta cell capacity remains, and what can be done to protect and support it.
Now that you understand what's actually happening at the cellular level in diabetes, it's easier to see why Glukora is formulated the way it is. Built around pure, cold-extracted Himalayan Picrorhiza Kurroa, Glukora targets the same pancreatic tissue and beta cell environment described above — supporting a reduction in the inflammation that exhausts beta cells in Type 2 diabetes, and supporting overall pancreatic cellular health.
- 100% organic Picrorhiza Kurroa root extract
- Targets pancreatic inflammation directly
- Supports beta cell environment in the Islets of Langerhans
- No fillers, synthetic additives, or chemicals
- 40-day structured course
- 60-day money-back guarantee
* These statements have not been evaluated by the FDA. Glukora is not intended to diagnose, treat, cure, or prevent any disease. Type 1 diabetes requires medical management; consult your physician before changing any diabetes treatment plan.
Frequently Asked Questions
Diabetes occurs when the pancreas cannot produce enough insulin, or the body cannot use insulin effectively. Insulin is the hormone that allows glucose to move from the bloodstream into your cells for energy. Without sufficient insulin function, glucose accumulates in the blood instead of being absorbed, leading to high blood sugar and, over time, damage to blood vessels, nerves, kidneys, and eyes. This is confirmed by the NIDDK's clinical overview of diabetes.
Beta cells are specialized cells located in clusters called the Islets of Langerhans within the pancreas. They are the only cells in the body that produce insulin. In Type 2 diabetes, beta cells become exhausted and gradually lose their ability to produce sufficient insulin. In Type 1 diabetes, the immune system directly destroys beta cells, eliminating insulin production almost entirely.
Type 1 diabetes is an autoimmune condition where the immune system destroys insulin-producing beta cells, usually starting in childhood or young adulthood, requiring lifelong insulin therapy. Type 2 diabetes develops gradually, typically in adulthood, as cells become resistant to insulin and beta cells become exhausted trying to compensate, eventually producing insufficient insulin. According to the CDC, Type 2 accounts for 90-95% of cases and is strongly linked to lifestyle factors, while Type 1 makes up the remaining 5-10% and is not preventable through lifestyle changes.
Blood sugar rises in diabetes because insulin — the hormone responsible for moving glucose out of the bloodstream and into cells — is either insufficient or ineffective. When you eat carbohydrates, your digestive system converts them into glucose, which enters the blood. Normally, the pancreas releases insulin to let that glucose into your cells. In diabetes, this process fails at some point along the chain, so glucose remains trapped in the bloodstream at elevated levels.
Emerging research published in journals like the Journal of Ethnopharmacology suggests that reducing inflammation and oxidative stress in pancreatic tissue may support some recovery of beta cell function in Type 2 diabetes, particularly in earlier stages before extensive cell loss. This is an active area of scientific research, not a settled clinical guarantee. Type 1 diabetes presents a different challenge, since the immune system would need to stop attacking new or regenerated beta cells for any recovery to be sustained — a focus of ongoing research tracked by the American Diabetes Association.
The Islets of Langerhans are clusters of hormone-producing cells scattered throughout the pancreas, named after German pathologist Paul Langerhans, who first described them in 1869. They contain several cell types, including beta cells (insulin), alpha cells (glucagon), and delta cells (somatostatin). A typical adult pancreas contains roughly one million islets, collectively responsible for blood sugar regulation.
According to the CDC's National Diabetes Statistics Report, an estimated 38.4 million Americans — about 11.6% of the population — were living with diabetes as of the most recent data. Of these, approximately 90-95% have Type 2 diabetes. An additional 97.6 million adults are estimated to have prediabetes, a condition where blood sugar is elevated but not yet in the diabetic range.
Type 2 diabetes can sometimes be put into remission, particularly when caught early and addressed through significant weight loss, dietary changes, and exercise, according to research published in journals tracked by the American Diabetes Association. Remission means blood sugar returns to non-diabetic levels without medication, though beta cell function rarely returns to fully pre-diabetic capacity. The longer Type 2 diabetes has progressed and the more beta cell mass has been lost, the harder reversal becomes — which is why early intervention matters significantly.
References & Citations
- "The Discovery of the Islets of Langerhans". National Center for Biotechnology Information, U.S. National Library of Medicine.
- National Diabetes Statistics Report. Centers for Disease Control and Prevention, 2024.
- Diabetes Remission and Beta Cell Function Research. American Diabetes Association, Research Division.
- Journal of Ethnopharmacology. Studies on pancreatic inflammation and beta cell function, ScienceDirect / Elsevier.
- What Is Diabetes? National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Type 1 Diabetes Overview. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- The History of the Wonderful Thing We Call Insulin. American Diabetes Association.
- Understanding Diabetes Complications. Centers for Disease Control and Prevention.
- Insulin, Medicines, and Other Diabetes Treatments. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).
- Diabetes Fact Sheet. World Health Organization.